Evidence map›Paper›PMID 31196127›Full record

ArticleBMC cancer2019

Treatment with somatostatin analogs induces differentially expressed let-7c-5p and mir-3137 in small intestine neuroendocrine tumors.

Florian Bösch, Alexandr V Bazhin, Sabine Heublein, Katharina Brüwer, Thomas Knösel, Florian P Reiter, Christoph J Auernhammer, Markus O Guba, Christine Spitzweg, Jens Werner and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. The association of immunosurveillance and distant metastases in colorectal cancer.Journal of cancer research and clinical oncology · 2021
    Article
  6. The Role of miRNA in the Pathophysiology of Neuroendocrine Tumors.International journal of molecular sciences · 2021
    Review
  7. [miR-let-7c-5p inhibits invasion and migration of bladder cancer cells by targeting HMGA2].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2021
    Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Florian BöschDepartment of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, Marchioninistr. 15, 81377, Munich, Germany. florian.boesch@med.uni-muenchen.de.ORCID http://orcid.org/0000-0002-0250-9017
Alexandr V BazhinDepartment of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, Marchioninistr. 15, 81377, Munich, Germany.
Sabine HeubleinDepartment of Obstetrics and Gynecology, Heidelberg University Hospital, Heidelberg, Germany.
Katharina BrüwerDepartment of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, Marchioninistr. 15, 81377, Munich, Germany.
Thomas KnöselInstitute of Pathology, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.
Florian P ReiterDepartment of Medicine II, University Hospital, LMU Munich, Munich, Germany.
Christoph J AuernhammerDepartment of Internal Medicine 4, Ludwig-Maximilians-University Munich, Munich, Germany.
Markus O GubaDepartment of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, Marchioninistr. 15, 81377, Munich, Germany.
Christine SpitzwegDepartment of Internal Medicine 4, Ludwig-Maximilians-University Munich, Munich, Germany.
Jens WernerDepartment of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, Marchioninistr. 15, 81377, Munich, Germany.
Martin K AngeleDepartment of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, Marchioninistr. 15, 81377, Munich, Germany.
European Neuroendocrine Tumor Society · DELudwig-Maximilians-Universität München · DEHeidelberg University · DELMU Klinikum · DE

Funding

Novartis Pharma 1
6 · The paper itself

Abstract

backgroundDistant metastases frequently occur in gastroenteropancreatic neuroendocrine tumors. If hepatic surgery is not feasible, patients are treated with somatostatin analogs. However, the underlying mechanisms of action of this treatment remain to be defined. The aim of the present study was to analyze the micro-RNA expression profile inter-individually before and after the treatment with somatostatin analogs. MATERIAL AND

methodsTumor specimens of all included patients (n = 8) before and after the onset of a therapy with somatostatin analogs were analyzed and a micro-RNA expression profile (754 micro-RNAs) of each probe was generated. This analysis in an intra-individual setting was selected to avoid bias from inter-individual differences. The micro-RNA expression profiles were validated by qPCR. Patients with any other systemic treatment were excluded from the present study.

resultsEight patients were included in the present study of which all had neuroendocrine tumors of the small intestine with diffuse hepatic metastases. Grouped analyses revealed that 15 micro-RNAs were differentially expressed (3 up- and 12 downregulated) after the exposure to somatostatin analogs. Additionally, let-7c-5p and mir-3137 are concordantly regulated in the inter-individually analysis.

conclusionsThis is the first study analyzing the individual micro-RNA expression profile before and after a therapy with somatostatin analogs. Data from this study reveal that somatostatin analogs may in part exert their beneficial effects through an alteration in the micro-RNA expression profile.

Indexed as

AgedAntineoplastic AgentsBiological Variation, PopulationFemaleGene Expression ProfilingHumansIntestinal NeoplasmsIntestine, SmallMaleMicroRNAsMiddle AgedNeuroendocrine TumorsProspective StudiesSomatostatinAntineoplastic AgentsMicroRNAsMIRN3137 microRNA, humanmirnlet7 microRNA, humanSomatostatinIntra-individualmicroRNANeuroendocrine tumorSomatostatin

Identifiers

PMID31196127
PMCPMC6567424
OpenAlexW2952986952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.